A detailed history of Alaska Permanent Fund Corp transactions in Amgen Inc stock. As of the latest transaction made, Alaska Permanent Fund Corp holds 53,770 shares of AMGN stock, worth $18.1 Million. This represents 0.26% of its overall portfolio holdings.

Number of Shares
53,770
Previous 55,163 2.53%
Holding current value
$18.1 Million
Previous $15.7 Million 7.12%
% of portfolio
0.26%
Previous 0.23%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 07, 2024

SELL
$262.75 - $319.31 $366,010 - $444,798
-1,393 Reduced 2.53%
53,770 $16.8 Million
Q1 2024

Apr 09, 2024

SELL
$268.87 - $324.56 $238,756 - $288,209
-888 Reduced 1.58%
55,163 $15.7 Million
Q4 2023

Feb 01, 2024

SELL
$255.7 - $288.46 $1.07 Million - $1.21 Million
-4,196 Reduced 6.96%
56,051 $16.1 Million
Q3 2023

Oct 31, 2023

SELL
$218.65 - $271.46 $260,849 - $323,851
-1,193 Reduced 1.94%
60,247 $16.2 Million
Q2 2023

Jul 31, 2023

BUY
$214.27 - $253.37 $5.37 Million - $6.34 Million
25,040 Added 68.79%
61,440 $13.6 Million
Q4 2022

Feb 08, 2023

SELL
$229.03 - $291.01 $278,042 - $353,286
-1,214 Reduced 3.23%
36,400 $9.56 Million
Q3 2022

Oct 31, 2022

BUY
$224.46 - $253.15 $1.77 Million - $2 Million
7,884 Added 26.52%
37,614 $8.48 Million
Q2 2022

Aug 09, 2022

BUY
$230.71 - $256.74 $6.53 Million - $7.26 Million
28,296 Added 1973.22%
29,730 $7.23 Million
Q1 2022

Apr 26, 2022

SELL
$219.27 - $242.57 $438 - $485
-2 Reduced 0.14%
1,434 $347,000
Q4 2021

Feb 14, 2022

BUY
$198.88 - $227.6 $285,591 - $326,833
1,436 New
1,436 $326,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $180B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Alaska Permanent Fund Corp Portfolio

Follow Alaska Permanent Fund Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaska Permanent Fund Corp, based on Form 13F filings with the SEC.

News

Stay updated on Alaska Permanent Fund Corp with notifications on news.